Photo may have been deleted

YouTube, In Style

Last week, the mainstream media reported that Dr. Anthony Fauci funded horrific experiments on adorable beagle puppies.

However, it wasn't just beagles and monkeys that Dr. Fauci's National Institutes of Health (NIH) experimented on over the years.

Now comes word that Fauci funded drug experiments on orphaned children diagnosed with the AIDS virus in New York in 2004.

The AIDS orphans story was first reported on right-wing blogs. They also were first to report the beagle puppies story.

The NIH was also caught funding experiments on AIDS orphans at a New York City hospital in 2004.

Joshua Roberts/Getty Images

The Fauci-led NIH approved funding for experiments on hundreds of New York City orphans. Government agencies and pharmaceutical companies reportedly used the orphans in deadly AIDS drug trials.

In 2005, the city of New York hired the VERA Institute to form a final report on the drug trials. VERA was given no access to medical records for any of the children used in trials. Their report was published in 2008.

They reported that twenty-five children died during the drug studies, that an additional fifty-five children died following the studies (in foster care), and, according to Tim Ross, Director of the Child Welfare program at VERA (as of 2009), 29% of the remaining 417 children who were used in drug studies had died (out of a total 532 children that are admitted to have been used). Source

A worker who took care of some of the children said many of them immediately became ill and vomited after taking the drugs.

She said children who refused to take the drugs were operated on and gastric tubes were inserted into their stomachs to force feed them AZT.

The children, some as young as 1, were wards at the Incarnation Children's Center (ICC) in New York City. Their parents died of AIDS.

Watch the video below.

Photo may have been deleted


Merck is the latest pharmaceutical company to rush an experimental drug to market to treat the SARS-CoV-2 virus.

Merck announced Friday that it has developed an experimental oral drug that will reduce hospitalizations and deaths by 50% in people recently infected with Covid.

The company will ask the Food & Drug Administration (FDA) for emergency authorization to distribute the capsules.

The drug -- which some compare to Ivermectin and Tamiflu -- is intended as a treatment for people with Covid symptoms.

Former FDA Director Dr. Scott Gottlieb told CNBC that the trial results are clearly "profoundly" positive.

supersizer / E+ / Getty Images

Merck allegedly tested the drug on 700 unvaccinated people diagnosed with Covid-19 in a global study.

The volunteers were all considered "high risk" due to factors like age, and pre-existing medical conditions.

Merck's study found that 7% of volunteers in the control group that received the drug were hospitalized, and none of them died. While 14% were hospitalized and eight people died in the placebo group.

Dr. Gottlieb calls the test results a "a profound game-changer that we have an oral pill that had this kind of effect on patients who are already symptomatic."

Dr. Gottlieb also noted that the team that developed the drug "also invented the first successful antibody against ebola so this is a very good drug-development team."

The drug is intended to be taken in addition to the mRNA vaccines.